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hosted  the  nineteenth  annual  Leadership  Program  for 
Veterinary Students this year. The program’s tradition of 
excellence has drawn thousands of applicants, but only 
436  of  the  most  promising  students,  representing  57 
veterinary  colleges,  have  been  selected  to  participate. 
Although  the  life  experiences,  culture,  and  academic 
backgrounds  of  program  scholars  are  diverse,  all  have 
distinguished themselves in a variety of professional and 
personal  pursuits.  They  are  highly  motivated  individuals 
who possess the ability to excel as research scientists and 
public health professionals.
Research  is  the  foundation  of  the  Leadership  Program 
and  the  activity  around  which  all  other  activities  are 
structured.  Program  scholars  pursue  individual  projects 
under the guidance of Cornell faculty members who are 
successful  scientists  and  experienced  mentors.  Their 
investigations are conducted in state-of-the-art facilities 
within the unsurpassed intellectual environment of Cornell, 
an  Ivy  League  university  located  in  the  scenic  Finger 
Lakes region of New York State. Program scholars also 
participate in modules and workshops that are structured 
as  student-directed  learning  exercises.  Topics  include 
emerging infectious diseases and biodefense, leadership 
and  its  attendant  responsibilities,  and  modules  that 
illustrate  leadership  and  employment  opportunities  for 
veterinary  graduates  in  the  academy,  government,  and 
industry.  Vocational  counseling  is  featured  prominently 
in the program. The aim is to empower students to make 
informed  decisions  about  graduate  education  and  their 
careers.  A  field  trip  to  federal  research  facilities  is  an 
additional feature of the program.
Throughout its 19 years the Leadership Program has fulfilled 
its  principal  objective—to  provide  veterinary  students 
with  unique  learning  experiences  that  both  clarify  and 
strengthen their commitment to careers in science. One 
hundred and fourteen of these individuals have earned the 
PhD degree or are presently in training, while many others 
have been awarded other advanced degrees in science or 
veterinary public health. A legacy of the program has been 
the establishment of a network of alumni who have the 
motivation to assist one another and more junior colleagues. 
The desired outcomes of the initiative are strengthening of 
the infrastructure of veterinary science and contributions 
that broadly influence the biomedical sciences.
A Commitment 
to Excellence
David R. Fraser, BVSc, PhD
Co-Director
Douglas D. McGregor, MD, DPhil
Program Director
1Acknowledgements
The  Leadership  Program  for  Veterinary  Students  is 
made possible through awards from federal agencies, 
corporations,  foundations,  and  other  private-sector 
sponsors.  For  their  generous  support  this  year,  the 
program organizers thank:
National Institutes of Health
Albert C. Bostwick Foundation
Pfizer Inc
Boeringer-Ingelheim Co.
The Wellcome Trust
The program organizers also thank all of the facilitators, 
counselors,  and  mentors  who  took  part  in  the  2008 
program.  Thanks,  too,  to  Ms.  Melissa  Restifo,  the 
program coordinator, and to Ms. Ariana Blossom, Ms. 
Alexis  Wenski-Roberts,  and  Mr.  David  Frank  for  their 
dedicated assistance.
Finally,  the  organizers  congratulate  the  participating 
scholars—their  academic  achievements,  coupled  with 
their  dedication  to  discovery  and  service,  mark  these 
individuals as future leaders of the veterinary profession.
References
From time to time, Leadership Program organizers and 
their associates have described elements of the program, 
strategies for their implementation, and outcomes of this 
initiative. Recent publications include:
•	Promoting	 Science-Based	 Careers	 through	 Student-
Directed  Learning.  McGregor,  D.D.  and  Fraser,  D.R. 
Journal of Veterinary Medical Education (33: 294, 2006).
•	Counseling	Veterinary	Students	Who	Aspire	to	Careers	
in Science. McGregor, D.D. and Fraser, D.R. JAVMA 
(229:668, 2006).
•	Acquainting	 Veterinary	 Students	 with	 Careers	 in	 the	
Pharmaceutical Industry. McGregor, D.D., Fraser, D.R., 
Haven, M.L., and Hickey, Gerard. Journal of Veterinary 
Medical Education (34:139, 2007).
•	Career	 Paths	 of	 Alumni	 of	 the	 Cornell	 Leadership	
Program for Veterinary Students. Fraser, D.R., McGregor, 
D.D. and Gröhn, Y.T. Veterinary Record (accepted for 
publication, 2008).
Interested  parties  also  are  invited  to  visit  the  program 
website at www.vet.cornell.edu/OGE/Leadership.
2 Contents
  4  Agenda
  5  Program Scholars
  6  Activities
 14  Cornell’s Partnership with the NIH
 16  The USDA and Animal Agriculture
 18  Presentations and Prizes
 19  Program Scholars and Their Research
 33  Program Coordinator
 34  Facilitators and Counselors
 36  Housing
 37  Time Out
 38  Program Dinner
 39  Where Are They Now?
 47  What Did They Say?
Inside back cover  In the Limelight
32008 Leadership Program Agenda
  June 2  Opening Meeting
  June 3  Library Orientation
	 	 Biological	and	Chemical	Safety	Training
    Laboratory Orientation
  June 7	 Career	Discussion
    Leadership Discussion Pre-meeting
  June 9  Leadership Discussion
    Program Dinner
  June 12  National Institutes of Health
  June 13  United States Department of Agriculture
  June 16  Radiation Safety Training
  June 30  Emerging Diseases Workshop
  July 1  Biodefense and Public Health Workshop
  July 7  Drug Design Workshop
  July 9  Reunion Dinner
  July 14	 Careers	in	Industry	Workshop
  July 16  Leadership in Action
  July 21  Residency Training
  July 22  Research Training
  July 23  Translational Science
  August 6  Research Presentations
  August 7  Research Presentations
  August 8  Exit Meeting 
42008 Leadership Program Scholars
Name  College  Mentor  Department  Sponsor
Rachel Acciacca  North Carolina State University  Joel Baines  Microbiology/Immunology  Pfizer Inc.
Hannes Bergmann  Leibniz Universität Hannover  Scott Coonrod  Baker Institute  Boehringer-Ingelheim Co.
Jennifer Bernard  University of Tennessee  Gary Whittaker  Microbiology/Immunology  NIH
Jennell Bigrigg  The Ohio State University  Scott Coonrod  Baker Institute  NIH
Anna Byron  University of Sydney  Marjory Brooks/James Catalfamo  Population Medicine/Diagnostic Sciences  Bostwick Foundation
Lucie Chevallier  École Nationale d’Alfort  Gregory Acland/Anna Kukekova  Baker Institute  Bostwick Foundation
Anne Dijkshoorn  Universiteit Utrecht  William Horne  Clinical Sciences  Pfizer Inc.
Katharina Dinger  Freie Universität Berlin  Holger Sondermann  Molecular Medicine  Pfizer Inc.
Johanna Dups  University of Queensland  Rick Cerione/Mark Antonyak  Molecular Medicine  Pfizer Inc.
Elsa Garcia  Cornell University  Susan Bliss  Baker Institute  NIH
Prabhpreet Gurmit Singh  University of Sydney  Nathan Sutter  Clinical Sciences  Bostwick Foundation
Anna Heymer  Leibniz Universität Hannover  John Parker  Baker Institute  Pfizer Inc.
Lisa Holz  Leibniz Universität Hannover  Lorin Warnick  Population Medicine/Diagnostic Sciences  Boehringer-Ingelheim Co.
Jennifer Irving  Royal Veterinary College  Susana Mendez  Baker Institute  Wellcome Trust
Sally Ann Iverson  Cornell University  Craig Altier  Baker Institute  NIH
Sophie Kay  Royal Veterinary College  Alexander Travis  Baker Institute  Wellcome Trust
Joshua Leach  Cambridge University  Yrjö Gröhn  Population Medicine/Diagnostic Sciences  Wellcome Trust
Ming Lui  Cornell University  Colin Parrish  Baker Institute  NIH
Katherine McKelvey  Cornell University  Alan Nixon  Clinical Sciences  NIH
Joanna Mleczko  Freie Universität Berlin  Drew Noden  Biomedical Sciences  Bostwick Foundation
Anna Moore  University of Bristol  Katherine Houpt  Clinical Sciences  Wellcome Trust
Dallas New  Ontario Veterinary College  Lisa Fortier  Clinical Sciences  NIH
Annelies Nijdam  Universiteit Utrecht  Chris Schaffer  Biomedical Engineering  Bostwick Foundation
Ellen Petermeier  University of Minnesota  Michael Stanhope  Population Medicine/Diagnostic Sciences  NIH
Jessica Privett  University of Sydney  Klaus Osterrieder  Microbiology/Immunology  Pfizer Inc.
Kimberley Schiller  University of Edinburgh  Klaus Beyenbach/Peter Peirmarini  Biomedical Sciences  Wellcome Trust
James Swann  Cambridge University  Ted Clark  Microbiology/Immunology  Wellcome Trust
Heidi Vesterinen  Helsinki University  Yrjö Gröhn  Population Medicine/Diagnostic Sciences  Bostwick Foundation
5The Leadership Program combines faculty-guided 
research  with  student-directed  learning  through 
participation  in  modules,  workshops,  and  group 
discussions.  The  activities  encourage  respon-
sible leadership; the development of critical think-
ing, communication, and teamwork skills; and an 
awareness  of  professional  training  opportunities 
that will enable program alumni to broadly impact 
the veterinary profession.
Research
Independent research is the foundation of the pro-
gram. Each scholar is assigned a project and a fac-
ulty mentor to guide his or her investigations. The 
projects enable the students to gain practical ex-
perience by exploring problems of interest to them. 
Simultaneously, they hone the students’ communi-
cation skills through engagement in group modules 
and presentation of research findings in a public 
forum at the conclusion of the program.
Activities 2008
6Leadership
Leadership  and  its  attendant  responsibilities  are 
central considerations in the Leadership Program. 
Critical	thinking	and	decision-making	are	featured	
in a scenario-based module that explores veteri-
nary public health, economic, political, and social 
issues. As the scenario unfolds, students and fa-
cilitators are assigned roles that oblige them to ar-
ticulate, defend, and sometimes alter their views. 
At  the  conclusion  of  the  module,  the  facilitators 
comment on the exercise and discuss leadership 
principles that have guided their careers.
This year, Dr. David Fraser moderated the discussion 
with assistance from Professor Malden Nesheim, 
Mr. Andrew Sage II, and Dr. Roy Pollock.
7Leadership in Action
The  film  entitled,  A  Few  Good  Men,  illustrates 
strengths  and  deficiencies  of  individuals  cast  in 
the role of leaders. A thoughtful discussion of the 
film was facilitated by Ms. Suzanne McGregor, and 
Professors Maurice (Pete) White, David Fraser, and 
Douglas McGregor.
Emerging Diseases
A	workshop	moderated	by	Professors	Colin	Par-
rish, John Parker, Alfonso Torres, and Drs. Philip 
Carter	and	Fred	Murphy	featured	a	discussion	of	
diseases that are emerging or re-emerging in na-
ture. From a prepared list, the program scholars 
selected  four  diseases  on  which  to  focus.  They 
conducted library research on the diseases, then 
engaged their peers and the facilitators in lively and 
informative discussions. Later in the evening, the 
facilitators commented on related issues and the 
need for veterinary scientists who contemplate ca-
reers in infectious disease research and veterinary 
public health.
8Biodefense
A similarly structured workshop addressed prob-
lems connected with the deliberate release of in-
fectious agents that can have catastrophic conse-
quences	for	animals	and	people.	As	in	the	Emerging	
Diseases Workshop, the scholars prepared for the 
exercise by conducting independent research on 
selected diseases and presented their findings in a 
public forum.
The panel of facilitators who took part in the Emerg-
ing Diseases Workshop were involved again in this 
meeting. During the evening session, the facilitators 
commented on their experiences and the prepara-
tion	required	for	veterinarians	to	function	as	public	
health professionals.
9Drug Design
Dr. Michelle Haven of Pfizer, Inc. moderated a com-
petition between mock companies formed by the 
students. The competition enabled the students to 
display creativity and teamwork in resolving prob-
lems connected with the discovery, development, 
and marketing of therapeutic drugs. Dr. Kirk Adams 
assisted Dr. Haven in this exercise.
Later  the  same  evening,  the  two  facilitators  an-
swered	questions	regarding	the	range	of	employ-
ment opportunities for veterinarians at Pfizer and 
the	advanced	training	required	to	be	competitive	
for such positions.
10Working in Industry
Drs.	Gerard	Hickey,	Margaret	McCann,	and	Charlie	
Hsu conducted mock interviews for three positions 
in	the	pharmaceutical	industry—and	Merck	Co.	in	
particular. The students prepared for the interviews 
by reviewing the resumés of prospective applicants 
and submitting application letters for the positions.
On the day of the meeting, the facilitators com-
mented	on	the	letters	and	posed	questions	to	the	
students	that	explored	their	qualifications	and	per-
sonal interests.
11Career Explorations
Career	planning	is	featured	prominently	in	the	Lead-
ership Program. Four meetings were convened to 
consider opportunities for veterinary graduates to 
broadly influence the veterinary profession through 
careers in the academy, government, and industry.
Professor David Fraser and Drs. Sandra Barnard 
and  Bruce  Kornreich  commented  on  the  impor-
tance  of  a  veterinary  degree  for  individuals  who 
aspire to careers in science. The three counselors 
emphasized the importance of selecting a supe-
rior environment for research training and a mentor 
who has a successful training record.
Professors  Lisa  Fortier  and  Sean  McDonough 
commented on residency programs in the clinical 
sciences and pathology, respectively. The facilita-
tors emphasized factors that one should consider 
in seeking a residency, the expectations of training 
organizers, and the satisfaction of a clinical or vet-
erinary service career.
12A companion meeting addressed issues relevant 
to graduate research training. Professors Richard 
Cerione,	Ruth	Collins,	John	Parker,	and	Douglas	
McGregor  identified  aspects  of  training  that  one 
should weigh in selecting an institution for gradu-
ate study, the subject of one’s thesis research, and 
an individual to guide one’s graduate work.
In  a  separate  meeting,  a  case  study  illustrated 
“translational science.” The ensuing discussion led 
by Professor William Horne revealed how an indi-
vidual trained to a high level of proficiency as both a 
clinical specialist and research scientist can extend 
the frontiers of knowledge through his or her ca-
pacity to define disease mechanisms at the cellular 
or molecular level.
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13NIH
Cornell’s Partnership with the 
National Institutes of Health
The	National	Institutes	of	Health	and	the	Cornell	
University	 College	 of	 Veterinary	 Medicine	 have	
forged a partnership that offers program scholars 
an opportunity to learn about research conducted 
at the nation’s premier biomedical research institu-
tion. This year’s participants gathered on the main 
campus of the NIH for a full day of scientific presen-
tations and discussions. Speakers included distin-
guished scientists and administrators drawn from 
the agency’s intramural research program.
14Agenda
Welcome and Introduction
Patricia M. Sokolove, PhD, deputy director, Office 
of Intramural Training and Education
“The Cornell/NIH Partnership”
Douglas D. McGregor, MD, DPhil, director, 
Leadership Program for Veterinary Students, 
College	of	Veterinary	Medicine,	Cornell	University
“Cytokines and Other Risk Factors in 
Drug-Induced Liver Disease”
Lance R. Pohl, PharmaD, PhD, chief, 
Molecular	and	Cellular	Toxicology	Section,	
National Heart, Lung, and Blood Institute
Q&A with Dr. Pohl
“Opportunities for Applying Mouse Models 
in the Discovery of Proteomic Molecular 
Diagnostics for Human Disease”
R. Mark Simpson, DVM, PhD, 
Laboratory	of	Cancer	Biology	and	Genetics,	
National	Cancer	Institute
Q&A with Dr. Simpson
“Neonatal Imitation in Rhesus Monkeys”
Stephen J. Suomi, PhD, chief, 
Laboratory	of	Comparative	Ethology, 
National	Institute	of	Child	Health	and 
Human Development
Q&A with Dr. Suomi
“Gene Therapy for Canine Leukocyte-
Adhesion Deficiency”
Dennis D. Hickstein, MD, 
Experimental Transplantation and 
Immunology	Center	for	Cancer	Research, 
National	Cancer	Institute
Q&A with Dr. Hickstein
“Preclinical Development of Hematopoietic 
Stem-Cell Gene-Transfer Techniques for 
the Treatment of Human Blood Diseases”
John F. Tisdale, MD, 
Molecular	and	Clinical	Hematology	Branch,	
National Institute of Diabetes and Digestive 
and Kidney Diseases
Q&A with Dr. Tisdale
15USDA
The USDA and Animal Agriculture
The  United  States  Department  of  Agriculture  is 
another valued partner in the Leadership Program. 
This year’s scholars visited the USDA’s Animal and 
Natural Resources Institute in Beltsville, Maryland. 
Institute  scientists  commented  on  their  research 
and  opportunities  for  advanced  training  at  this 
prestigious institution.
16Agenda
Introduction and Overview of the 
Beltsville Agricultural Research Center
Dr. Morse B. Solomon, acting associate director, 
Animal and Natural Resources Institute
“Genetic Engineering in Livestock on 
a Large Scale: Transgenic Livestock”
Dr. Robert Wall, research physiologist, 
Biotechnology and Germplasm Laboratory
“Swine as a Model for Human Allergic and 
Infectious Disease Interactions”
Dr. Gloria Solano-Aguilar, microbiologist, 
Genomics and Immunology Laboratory
“Searching for Disease-Resistant Genes 
in Cattle”
Dr. Louis Gasbarre, research leader, 
Bovine Functional Genomics Laboratory
17The Leadership Program scholars discussed their research in a series of presentations 
over two days at the conclusion of the program.
A book prize was awarded to Katharina Dinger for best overall research achievement as 
judged by the underlying hypothesis, investigative protocol, results, and presentation.
Additional prizes were awarded to Hannes Bergmann, Anne Dijkshoorn, and Sally Ann 
Iverson for exceptional achievements in integrative biology, cell biology, and molecular 
biology, respectively.
The	Selection	Committee	for	the	2008	Leadership	Program	salutes	these	individuals	and	
congratulates the entire group for their commitment to research and for the excellence of 
their presentations.
Presentations 
  and Prizes
Program Prize
Katharina Dinger
Kinetic Studies of 
Inhibition of WspR in 
Pseudomonas aeruginosa
Integrative Biology Prize
Hannes Bergmann
Identification of Dog MATER and 
Other Oocyte-Specific Proteins 
Essential for Early Development
Cell Biology Prize
Anne Dijkshoorn
Concentration-Dependent	Effects	
of the α2δ Subunit on 
Cav2.1	Ca2+	Channel	Expression
Molecular Biology Prize
Sally Ann Iverson
Analysis of In Vivo–Activated 
Genes of Salmonella typhimurium
18Program 
Scholars  
 
and their Research 2008
Rachel Acciacca | North Carolina State University, Virology
How Herpes Simplex Virus Type 1 Exits the Nucleus
The Cornell Leadership Program has introduced me to many exciting opportunities within 
the field of veterinary medicine and has highlighted the need for veterinarians in science 
and public health. My professional interests are in global public health and emerging 
zoonotic diseases. I applied to the Cornell Leadership Program to learn more about these 
fields. After graduating with the DVM degree in 2011, I will serve active duty in the U.S. 
Army Veterinary Corps. I am looking forward to serving my country at home and abroad, 
as an Army officer devoted to a career in veterinary public health.
My research at Cornell has focused on the envelopment of herpes simplex virus type 
I (HSV-1) nucleocapsids at the inner nuclear membrane. During herpesvirus infection, 
herpes simplex nucleocapsids assembled in the nucleoplasm acquire an initial envelope 
by budding through the inner nuclear membrane of infected cells. During this process, 
the HSV-1-encoded UL34 protein associates with the inner nuclear membrane to create 
specific envelopment sites. Using indirect antibody fluorescence assays, I investigated 
the role of HSV-1 UL13 protein kinase in determining UL34 protein localization at the 
inner nuclear membrane.  It appears that this viral kinase may be required for even dis-
tribution of UL34 proteins around the nuclear rim of wild-type-virus-infected cells.
I want to thank Dr. Joel Baines and Liz Wills for their mentorship, and all of the members 
of the Baines lab for their valuable guidance. I also want to thank Dr. Douglas McGregor 
and Dr. David Fraser for my opportunity to participate in this program and for their 
wholehearted dedication to its success.
19Hannes Bergmann | Leibniz Universität Hannover, Reproductive Biology
Identification of Dog MATER and Other Oocyte-Specific Proteins 
Essential for Early Development
I have always been interested in gaining in-depth understanding about questions that 
captivate me. Therefore, I was elated by the opportunity to pilot a research project over 
the summer at the Baker Institute. Even though I will always maintain clinical skills within 
my future career, I am enthusiastic about the possibility of contributing to the profession 
at a more fundamental level than would be possible solely as a clinician.
As a part of the research component of the Leadership Program, I aimed to make a 
contribution to the development of immunocontraceptives for dogs and cats. In the epi-
genetic and reproductive biology laboratory of Scott Coonrod, I explored the possibility 
of using the protein MATER as the target of a contraceptive vaccine. The autoimmune 
disease of premature ovarian failure in humans and related findings in mice strongly 
suggest that the MATER protein plays a crucial role as a highly specific autoantigen. In 
order to develop an autoantigenic vaccine that triggers an oocyte-specific cellular im-
mune response, I investigated different dog tissues, using PCR to confirm the expression 
of MATER and other oocyte-specific proteins essential for early development in cats and 
dogs. I finally focused on ovarian tissue and oocytes, employing immunohistochemistry 
and immunofluorescence to determine the distribution of this protein within the ovary.
During this highly informative program, I gained a better understanding about research-
related career options in veterinary medicine. In addition, by independently conducting a 
scientific project, I gained insight into basic research. I would like to thank Drs. Coonrod 
and Brian Cherrington for their guidance.
Jennifer Bernard | University of Tennessee, Virology
Cellular Entry of Feline Infectious Peritonitis Virus by the 
Fc Receptor-Dependent Pathway
I started veterinary school with the desire to pursue a career outside of private practice, 
particularly in zoo medicine or pathology. I applied to the Veterinary Leadership Program 
in order to explore such careers. I now have learned about many careers that seem both 
engaging and rewarding. After veterinary school, I plan to finish my MPH and obtain 
advanced training in anatomical pathology.
During the summer I worked with feline infectious peritonitis virus (FIPV) in the laboratory 
of Gary Whittaker. FIP is a deadly disease of cats for which no treatment is available. Pre-
vious studies show that if cats are producing antibodies to FIPV and are challenged with 
a virulent form of FIPV, they develop FIP more rapidly and with more severe clinical signs 
than cats that are not producing antibodies to the virus. It is thought that virus-antibody 
complexes are formed that bind to Fc receptors of macrophages, thus facilitating the 
entry of the virus by bypassing the conventional route of virus entry into cells.
The purpose of my project was to investigate the molecular mechanism involved in the 
entry of FIPV into macrophages through the Fc receptor endocytic pathway. We found 
that clathrin may be a necessary component of the alternative entry pathway. These find-
ings may suggest that molecular targets can be identified for a new therapeutic strategy 
in the treatment of FIPV.
Thank you to Douglas McGregor and David Fraser for the opportunity to participate in 
the Leadership Program. My mentor Gary Whittaker and Andrew Regan deserve special 
thanks for an excellent lab experience.
20Jennell Bigrigg | The Ohio State University, Cancer Biology
PADI4 Expression in Mouse Models of Breast Cancer
As a third-year veterinary student, I have a strong interest in research. I applied to the 
Leadership Program to gain a better understanding of non-traditional careers available 
to veterinarians. After graduation, I intend to continue my education in a PhD/residency 
program and eventually to pursue a career in either industry or the academy.
During the past summer, I had the privilege of working in Dr. Scott Coonrod’s lab, where 
I investigated expression patterns of PADI4 in mouse models of breast cancer. PADI4 is 
a member of a calcium-dependent enzyme family that citrullinates arginine residues on 
histone tails, creating major alterations in chromatin structure that can lead to changes 
in gene transcription, epigenetic regulation, and potentially cancer. Despite the links of 
PADI4 to reproduction and reproductive-associated cancers, little is known about the 
location of PADI4 expression in mouse reproductive tissues. Using western blot and im-
munohistochemical techniques in wild type and PADI4 knockout mice, I demonstrated 
the location of PADI4 expression and showed that PADI4 knockout mice could be a valu-
able model for investigating human female reproductive cancers.
The Leadership Program has been an unforgettable experience and has opened my eyes 
to many new opportunities. During my summer at Cornell, I met many amazing people, 
both researchers and students. It has been a pleasure to associate with individuals who 
have career goals and aspirations similar to mine. I would like to thank the Coonrod 
laboratory members for their support and guidance, especially Drs. Scott Coonrod and 
Brian Cherrington.
Anna Byron | University of Sydney, Hematology
Platelet-Driven Thrombin Generation in a Canine Model 
of Scott Syndrome
My  passion  has  always  been  veterinary  medicine,  although  I  completed  a  medical 
science degree prior to studying veterinary science. The latter allowed me to develop 
specific research interests in neurophysiology and hematology. I was therefore fortunate 
to work with Dr. Marjory Brooks and Dr. James Catalfamo over the summer, pursuing my 
interest in the coagulation aspect of hematology.
My project focused on Scott syndrome, a bleeding disorder that has been identified in 
humans and dogs. Platelets of these patients are unable to promote normal coagula-
tion, as the binding site for coagulant proteins such as factors VII, VIII, IX, and X is not 
exposed. This binding site, a lipid that normally makes up part of the platelet membrane, 
is phosphatidylserine. We have developed a system in which we can observe the effects 
on coagulation of different agonists—such as collagen, factor Xa, and tissue factor—in 
affected dogs when compared to a control. By measuring thrombin generation, we were 
able to identify significant deficiencies in coagulation in response to collagen and tissue-
factor stimulus, as well as reduced microparticle (platelet fragment) activity in affected 
dogs. Interestingly, factor Xa was shown for the first time to be able to stimulate external-
ization of phosphatidylserine in normal dogs in the absence of any other agonist.
I would like to offer sincere thanks to my mentors, Dr. Brooks and Dr. Catalfamo, and 
my new best friend, Wiggles (one of the affected dogs). This has been an enlightening 
summer. The excellent guidance and company in the lab have made it a fantastic and 
motivational experience.
21Lucie Chevallier | École Nationale d’Alfort, Genetics
Evaluation of a Candidate Gene for 
Canine Multifocal Chorioretinopathy
Genetics has always inspired my passion. During an internship in a French genetic labo-
ratory I realized how powerful the dog model is for studying human genetic diseases. 
I wanted to capitalize on any opportunity to study canine genetics more deeply. I applied 
to the Leadership Program with the hope of having a wonderful experience in genetics, 
to learn about career paths, and to meet accomplished researchers. My expectations 
were fulfilled!
I worked this summer on an ocular disease of dogs: canine multifocal chorioretinopathy 
(CMC). The cause of this disease, which affects many breeds, is unknown. CMC affects 
dogs submitted to strenuous exercise. Males are at least three times more often affected 
than females, which suggests that if the disease has a genetic cause, the responsible 
gene may be located on the X chromosome. Indeed, an X-linked disease in humans that 
is similar to CMC is caused by mutations in the choroideremia gene located on the X 
chromosome. The objective of my research was to determine whether the choroideremia 
locus is implicated in CMC in dogs. We identified single nucleotide polymorphisms (SNPs) 
located in and around the choroideremia gene, and genotyped these SNPs in a popula-
tion of normal and affected Borzoi dogs. Analysis of SNP haplotypes failed to reveal an 
association between choroideremia locus and the CMC. Thus, the choroideremia locus 
can be excluded as a candidate gene for canine multifocal chorioretinopathy in Borzois.
I would like to thank Greg Acland and Anna Kukekova for being such wonderful men-
tors. I also would like to thank Dr. Douglas McGregor and Professor David Fraser for 
their time and energy and for the great experiences they arranged for us during these 
10 unforgettable weeks.
Anne Dijkshoorn | Universiteit Utrecht, Molecular Biology
Concentration-Dependent Effects of the α2δ Subunit on 
Caʋ2.1 Ca2+ Channel Expression
Fascinated by science, I completed a one-year research project following my preclini-
cal studies at the University of Utrecht. During that year I became increasingly aware of 
the many fields that excite me. During my first year of clinical rotations, I applied to the 
Cornell Veterinary Leadership Program to explore the possibilities for a future career. 
In this ever-changing and dynamic world, I am intrigued by the challenge of combining 
veterinary knowledge with science and other related fields.
My project focused on neuronal high-voltage-activated Caʋ2.1 Ca2+ channels. Knowl-
edge of these channels at the molecular level can lead to the understanding and design 
of drugs directed to chronic and neuropathic pain. The primary technique of the study 
involved the use of a two-electrode voltage clamp. Xenopus laevis oocytes do not express 
Ca2+ channels naturally. When injected with mRNA encoding three Ca2+ channel subunits 
(α1; α2δ-1; β), the oocyte expresses functional Ca2+ channels on the cell surface. Since 
α2δ subunits are up-regulated in neuropathic pain, I studied the effects of increasing 
the concentration of α2δ on Ca2+ channel current expression and gating.
My experiments lead to three novel findings: expression of Caʋ2.1 Ca2+ channels does 
not require the α2δ subunit; increasing the ratio of α2δ from 1:0:1 to 1:1:1 has only a 
modest effect on Ca2+ current expression; and, contrary to what has been hypothesized 
in the literature, α2δ ratios greater than 1:3:1 actually inhibit (rather than enhance) 
Ca2+ current expression.
I thank Bill Horne and Johanna Holm for their motivating and invaluable mentoring. I am 
also grateful to everyone who, by being amazingly dedicated and enthusiastic, made this 
program such an impressive experience.
22Katharina Dinger | Freie Universität Berlin, Bacteriology
Kinetic Studies of Inhibition of WspR in Pseudomonas aeruginosa
Being a curious person and looking for a career option that satisfied my questioning 
mind, I decided to study veterinary medicine. Five years later, I am still convinced that 
there is no other profession that provides such a broad knowledge about the plethora of 
interactions between different species and the environment.
In the course of my Leadership Program project at the Sondermann lab, I was able to 
explore one aspect of these interactions by studying biofilm formation, which is a fre-
quent phenomenon in bacterial colonization. When attached to a surface, formerly free-
floating microorganisms secrete an extracellular matrix, the biofilm. This heterogeneous 
substance creates optimal living conditions and attracts further bacterial colonization. 
Currently more than 80 percent of chronic infections are attributed to biofilm formation, 
and nearly 70 percent of cystic fibrosis patients die due to secondary infection with 
Pseudomonas aeruginosa, an efficient biofilm-former. Inhibition of biofilms offers the 
prospect of developing novel antibiotics. Although many factors for biofilm formation 
are still unknown, the enzyme WspR, an active diguanylate cyclase from Pseudomonas 
aeruginosa, was recently identified as a major component. I tested the effect of several 
inhibitors on WspR using kinetic studies, Congo Red assays, and crystallization experiments.
I would like to thank Dr. McGregor and Dr. Fraser for being more than facilitators and 
counselors—they are the heart of this leadership program! I also would like to thank 
the entire Sondermann lab for skillful and patient guidance, especially Nabanita De and 
Holger Sondermann for their support. Last but not least, Melissa Restifo and the rest of 
the Zeta Psi Group—it was wonderful to have you all around!
Johanna Dups | University of Queensland, Cancer Biology
Tumor-Derived Microvesicles: 
Novel Method of Cancer Dissemination
I was three years into my veterinary studies when I had my first lecture on public health. 
Suddenly a whole new realm of professional possibilities for the veterinary scientist be-
came apparent. The Cornell Leadership Program has provided an excellent opportunity 
to explore this concept further.
This summer I had the privilege to work in Dr. Richard Cerione’s laboratory under the 
mentorship of Dr. Marc Antonyak. Recently it was shown that microvesicle formation in 
a glioma cell line was responsible for transfer of oncogenic material from cancerous to 
non-cancerous cells. This presented a whole new model for cancer dissemination. We 
saw that similar microvesicles could form with a cervical carcinoma cell line, HeLa.  How 
they were regulated became the basis of my research project, and I focused on ques-
tions with clinical relevance. Do microvesicles from HeLa cells lines confer oncogenic 
activity on non-cancerous cell lines or increase malignancy in benign cancer-cell lines? 
What, if any, signaling mechanisms are important for microvesicle formation, and what 
specific proteins are contained within the microvesicles? I found that small GTPase, Rho, 
activity was critical for formation of microvesicles and that the pro-survival protein, tis-
sue transglutaminase, is one of the proteins present in the microvesicle. These findings 
provide evidence for a novel way of cancer progression and also suggest possible points 
for clinical intervention.
Working in the Cerione laboratory was a once-in-a-lifetime introduction to scientific re-
search at the highest level. Marc Antonyak and Richard Cerione were absolutely fantastic 
mentors, and I can’t thank them enough. I would also like to extend an enormous thank 
you to Douglas McGregor and David Fraser for an absolutely inspiring summer.
23Elsa Garcia | Cornell University, Immunology
The Hepatoprotectant Role of Intestinally Derived CD4+ T Cells 
in IL-10 Knockout Mice
I am in the second year of my veterinary education. In the course of my veterinary train-
ing, I discovered appealing opportunities for careers in research and academia. I applied 
to the Veterinary Leadership Program to explore my interests in immunology, pathology, 
and a scientific career. The Leadership Program has provided me with an invaluable 
research experience that has influenced my career goals. The workshops, career discus-
sions, and networking opportunities provided the guidance I needed to decide between a 
career in clinical practice, academia, or research. After graduation, I would like to pursue 
a pathology residency and perhaps a career in academia.
My studies during the summer investigated the immunological relationship between the 
intestine and the liver. In diseases such as inflammatory bowel disease, disease oc-
curs in the liver as well as the intestine. For my project, we focused specifically on the 
hepatoprotective role of intestinal CD4+ T cells. Our results indicated that CD4+CD25+ 
regulatory T cells did not protect the liver during inflammation. However, other regulatory 
T cells may have a protective role. We also determined that intestinal CD4+ T cells in the 
liver produce the cytokines IL-4, IL-10, and IL-22.
I am sincerely thankful to Dr. Susan Bliss and Diana Douglas for their concern, patience, 
and help during the summer.
Prabhpreet Gurmit Singh | University of Sydney, Genomics
Candidate Genes for Body Size in Dogs
The Cornell Leadership Program was first brought to my attention when I was doing a 
one-year research degree in exotic bird nutrition between my fourth and final years of 
vet school. It seemed like a great opportunity to explore different fields of research while 
meeting a wide variety of people. I am hoping to use some of the skills that I have ac-
quired and continue with some of the projects in which I have been involved during this 
program when I begin my employment as a veterinarian in the Agri-Food and Veterinary 
Authority of Singapore.
I spent the summer at Cornell with a fantastic group of researchers, under the supervi-
sion of Professor Nathan Sutter. Members of the Sutter lab select candidate genes for 
size in domestic dogs based on the actions of the proteins for which they code. These 
are sequenced using genomic DNA extracted from six giant- and six toy-breed dogs. 
The sequences are then compared, and single nucleotide polymorphisms, insertion-
deletions, and microsatellite mutations are identified. If a marker is found that shows 
distinct differences between small and large dogs, the sequencing is repeated using a 
larger number of genomic DNA samples. I worked on two distinct genes during my time 
in the lab and discovered 15 markers, although none of them were significantly associated 
with body size.
The Leadership Program was absolutely brilliant. I really enjoyed working in a field that 
was completely different from my own. I would like to thank everyone at my lab, espe-
cially Nate Sutter and Jeremy Allen, as well as Dr. McGregor and Dr. Fraser for being so 
supportive and making this program an unforgettable experience.
24Anna Heymer | Leibniz Universität Hannover, Virology
Development of an FCV-5-Urbana Chimeric Virus
This fall, I will start my fifth year at the Leibniz Universität in Hannover, Germany. During 
my studies, I became increasingly interested in scientific research, especially in infec-
tious diseases. The Leadership Program was an excellent chance to broaden my knowl-
edge in virology and in research in general, and to gain valuable career advice.
I worked in John Parker’s lab at the Baker Institute this summer, where I studied feline 
caliciviruses (FCVs). FCVs are common pathogens of cats in which they usually cause un-
apparent infections or oral- and mild upper-respiratory-tract-disease. Recently, however, 
new highly virulent strains have emerged that cause systemic disease with high mortality.
FCV is a nonenveloped virus with a single-stranded, positive sense RNA genome that 
contains three open-reading frames (ORF). ORF1 encodes viral nonstructural proteins, 
whereas ORFs 2 and 3 encode the major and minor structural proteins of the virus. 
It is not known which changes have occurred to make the new strains highly virulent. 
For this reason I worked on developing a chimeric virus containing the nonstructural 
genes of low-virulent FCV-Urbana and the structural genes of the high-virulent strain, 
FCV-5. The chimeric virus will be used in future experiments to determine if struc-
tural proteins from highly virulent isolates, expressed in the background of low-virulent 
isolates, alter virulence.
The Leadership Program showed me many career options that I will now consider, and 
it helped me develop both personally and professionally. Another invaluable experience 
was making international friends and useful contacts to veterinary scientists. I thank 
John Parker and Oz for their guidance.
Lisa Holz | Leibniz Universität Hannover, Epidemiology
Selection of Resistance Factors in E. coli in Dairy Cattle Treated 
with Ceftiofur
As I am starting my fourth year of vet school this fall, I wanted to learn more about the 
career paths that are open to veterinary graduates. This summer at Cornell gave me a 
great opportunity to strengthen my interest in research. Participation in the Leadership 
Program made me realize that my professional future lies in working with infectious 
diseases—either in academic research or in public health.
Reduced susceptibility (RS) to antibiotics in a variety of bacteria is an important and 
growing concern not only in veterinary medicine but also in public health. The goals of 
our study include comparison of RS induced by the use of different antibiotics (Ceftiofur 
vs. penicillin) by testing isolates of E. coli strains from fecal samples in dairy cattle with 
a view to determining whether cattle treated with Ceftiofur host more E. coli that are less 
susceptible to antibiotics than cattle treated with penicillin. For this purpose, a method of 
colony replication was established in our laboratory, using a hydrophobic grid membrane 
filter (HGMF)-technique. The filter system enabled us to examine a large number of 
E. coli isolates from a single fecal sample and to copy those isolates onto different antibi-
otic plates. Combined with special software, this technique allowed us to look at qualita-
tive and quantitative changes in microbial susceptibility in our study population.
I would like to thank Dr. Lorin Warnick and his lab for their support and effort in teaching 
me, as well as Dr. Douglas McGregor and Dr. David Fraser, who gave me the chance to 
see the broad opportunities that are open to me.
25Jennifer Irving | Royal Veterinary College, Parasitology
The Effect on Dendritic Cells of an Immunosuppression Factor Re-
leased by Hookworms
I decided to obtain a veterinary education because of my love of animals, but after doing 
an intercalated research year at a medical school, I realized that a degree in veterinary 
medicine could open many more opportunities than being a clinician. My interest in 
parasitology began when I completed a module in tropical parasitology at King’s College 
London. After I graduate I intend to enroll in a residency program in production-animal 
medicine as well as study for a master of public health degree. I shall then return to 
academia to pursue a PhD in parasitology. I hope that these qualifications will equip me 
for a career, relevant to both animal and human medicine, in either government agencies 
or academic institutions.
I spent my summer in the lab of Dr. Susana Mendez investigating a newly discovered 
protein, Ac-TMP2, produced by hookworms and thought to be immunosuppressive. My 
project involved exposing bone-marrow-derived dendritic cells to the Ac -TMP2 and us-
ing flow cytometry to assess changes in expression of cell-surface antigen-presenting 
molecules. I also used ELISA to measure changes in the production of IL-10 and IL-12. 
My data suggest that expression of MHC Class 1 and IL-12 increases after antigen ex-
posure. I also optimized a simple protocol to extract dendritic cells from mouse intestine 
so that Dr. Mendez can repeat this work using intestinally derived dendritic cells.
I am very grateful to Dr. Mendez and to everyone in her lab. The Leadership Program has 
been extraordinary and has left me better informed about how to follow a career path 
that will allow me to contribute a great deal, not just to veterinary medicine, but also to 
the world.
Sally Ann Iverson | Cornell University, Bacteriology
Analysis of In Vivo–Activated Genes of Salmonella typhimurium
After finishing my first year of veterinary school, I decided to participate in the Leadership 
Program for the opportunity to undertake a research project, as well as to further explore 
the many career options available to veterinarians. My interest in infectious disease led 
me to spend the summer working with Salmonella under the mentorship of Dr. Craig Altier.
Salmonellae are prominent and extensively studied bacterial pathogens. Although much 
has been learned through in vitro models, little is known about how Salmonella spp. 
regulate their virulence within animals. A previous screen performed in the Altier lab 
identified 55 Salmonella genes that are activated in vivo using a pig model. I chose 
several of these genes with the aim of discovering if they have an important virulence 
phenotype. I created mutant strains of Salmonella with deletions of the genes of inter-
est and performed assays for various phenotypes that may be important in an animal 
host, such as growth, motility, invasion, and nutrient acquisition. I found two genes that 
control the expression of invasion genes necessary for Salmonella to penetrate intestinal 
epithelium, a key step in infection of the host. These genes are potential novel regulatory 
mechanisms for Salmonella virulence in animals.
The Leadership Program has left me with wonderful ideas about the capabilities of vet-
erinarians and some great prospects for new directions in my career. I would like to 
thank my research mentor, Dr. Altier, as well as the lab members for their patience and 
guidance, and Dr. Douglas McGregor and Dr. David Fraser for their dedication in making 
this program a success.
26Sophie Kay | Royal Veterinary College, Reproductive Biology
Characterization and Expression of Raft-Associated Proteins 
throughout the Epididymis
I began university by studying science, with the intention of becoming a small-animal 
practitioner. However, after starting the veterinary medicine degree, I found that I missed 
the challenges and constant questioning of established knowledge—a feature of my 
previous training in science. Consequently, I applied to the Leadership Program to better 
explore future career opportunities.
The focus of my research project this summer was sperm maturation in the epididymis—
essential to achieve potential fertilization. During the transit of sperm, biochemical char-
acteristics of the sperm membrane change. Recent studies have shown that these al-
terations are brought about by the formation of membrane rafts, which are specialized 
regions enriched in lipids and proteins. The Travis lab has found that these rafts can 
act as targets for the addition of proteins secreted by the epididymis. These rafts also 
alter their localization within the membrane, in preparation for other functions once 
they enter the female tract. My project involved the localization of two raft-associated 
proteins (phospholipase B and apolipoprotein A) throughout the three main regions of 
the epididymis (caput, corpus, and cauda). The results showed significant variation in 
proteins present in membrane rafts throughout the epididymis and sperm plasma mem-
branes. These data have potential implications as to causes of infertility and may be 
useful in efforts to create a male contraceptive pill.
The Leadership Program has been an incredibly influential experience for me. It has 
reinvigorated my ambitions and provided me with the tools necessary for a successful 
career. I would like to thank Alex Travis and Atsushi Asano for their fantastic and sup-
portive mentoring—and Jacque Nelson for her help and encouragement.
Joshua Leach | Cambridge University, Epidemiology
Effect of Mastitis on Conception in Dairy Cattle
My career goal is to enter a profession that has an important role in spanning veterinary 
and human public health and that aims to reduce the economic and welfare burdens 
caused by the increasing threat posed by vector-borne infectious diseases.
I accepted a place in veterinary science at Cambridge because the university offers a 
strong scientific and applied academic grounding that would not have been covered in 
similar depth in other, more general, veterinary courses.
My research project in this summer’s Leadership Program aimed to determine the effect 
of mastitis on fertility in dairy cattle. This is a controversial and much-debated topic, with 
many previous studies contradicting one another and where no firm conclusions could 
be drawn because of lack of accurate primary data. The project posed many problems in 
model design and in the choice and implementation of relevant statistical tools. As with 
any epidemiological modeling, it is vital to avoid bias—and confounding when setting up 
the model and also when interpreting the results.
The results of this project have demonstrated a highly significant effect of mastitis in 
causing decreased conception rates at different time points around insemination. I have 
come to appreciate the power and importance of modeling in highlighting interactions 
that do not seem to be logical and in answering questions that appear to be easily an-
swerable but prove to be intractable by other techniques.
The summer of 2008 has been an enlightening and enjoyable experience from which I 
have learned many valuable lessons. To Professors David Fraser and Douglas McGregor 
and to Dr. Yrjö Gröhn, my mentor in the truest sense of the word: I express my gratitude.
27Ming Lui | Cornell University, Virology
Characterization of Canine Parvovirus Cellular Entry and 
Uptake Mechanisms
I entered veterinary school having gained research experience during my undergraduate 
years and with a strong interest in the emerging field of veterinary public health. It was 
with this dual interest that I applied as a first-year student to the Leadership Program, 
which promised to reveal new insights about the practical challenges and realities of 
pursuing a nontraditional veterinary career. 
Colin Parrish’s lab actively engages in different facets of parvovirus research, but my 
project focused on viral uptake and cellular entry of canine parvovirus (CPV). It is known 
that CPV enters the cell first by binding to the transferrin receptor and subsequently 
through clathrin-mediated endocytosis. However, the details of this binding and uptake 
process in the plasma membrane are unknown. Amongst the pieces of information need-
ed to clarify the process are the kinetics of virus transit, entry of the virus via clathrin-
independent mechanisms, as well as other requirements of cellular entry. To further 
elucidate these details, a system to visualize the events using real-time fluorescence 
microscopy was used. A hamster ovarian cell-line, TRVB2, which does not endogenously 
express the transferrin receptor and thus is not able to be infected with CPV, was trans-
fected with one of three different mutant transferrin receptors. One receptor was the 
wildtype control, and the other two differed in their cytoplasmic domains, changing their 
endocytotic pathways. After we ascertained that transfected TRVB2 cells were able to 
be infected with CPV, they were additionally transfected with clathrin-GFP and caveolin-
GFP constructs, yielding six doubly transfected cell-lines that were then imaged, and the 
resultant time-lapse movies analyzed. 
I am grateful to have been accepted into the marvelous Leadership Program and for the 
new friends I met through the program and the Parrish lab.
Katherine McKelvey | Cornell University, Molecular Biology
Role of Stably Integrated Sox Transcription Factors in 
Stem-Cell Chondrogenesis
I have always been interested in a nontraditional veterinary career and was naturally 
drawn to research. The Leadership Program is so valuable because of the variety of 
activities and information provided on post-graduate training such as residencies, public 
health/epidemiology, and pharmaceutical development. Hopefully, I can combine clinical 
medicine and research through completing a residency, followed by a PhD and postdoc-
toral training.
While in the program this summer I worked in Dr. Alan Nixon’s lab on equine chon-
drogenesis, focusing on the Sox family of transcription factors and their initiation of 
mesenchymal stem-cell  (MSC) differentiation. Cartilage injury and degeneration is a 
significant problem, causing lameness and acceleration of osteoarthritis in both horses 
and humans. Autologous grafts of mesenchymal stem cells, harvested from sternal bone 
marrow and grown in culture, decrease healing time and provide a source of cartilage 
progenitors but alone do not provide significant long-term improvement. In fetal develop-
ment, Sox transcription factors stimulate differentiation and development of cartilage, 
with the L-Sox5, Sox6, and Sox9 being the most critical. Cloning of these three genes 
and insertion into a plasmid expression vector, PXP3, shows in vitro expression of L-Sox5 
and Sox-6 in transduced MSCs. Analysis of equine Sox9 showed an anomalous coding 
sequence when compared to the human/mouse sequence, and the majority of my project 
was to correct the sequence using modern cloning techniques.
This summer has been amazing and unforgettable because of the advice and knowledge 
presented by guest facilitators and Leadership Program students—and also because of 
the work that both Dr. Douglas McGregor and Dr. David Fraser have put into the program. 
I would like to thank both of them as well as Dr. Nixon, Mike Scimeca, Ashlee Watts, 
Yang Gu, and Jeremy Ackerman-Yost for their patience and support.
28Joanna Mleczko | Freie Universität Berlin, Embryology
Mechanisms Controlling Patterned Angiogenesis 
in the Developing Hindbrain
When I enrolled in veterinary medicine in Berlin, I envisaged a career in farm-animal 
practice, since this is what I knew from childhood. However, as my studies proceeded, I 
discovered the great range of career opportunities available to me. Participation in the 
Leadership Program has provided insight into exciting alternative careers, such as in 
international public health or academic/corporate research.
My project investigated the control of angiogenesis—blood-vessel formation—during 
development of the hindbrain. The brain and spinal cord are the only epithelial structures 
that are penetrated by blood vessels; in the hindbrain this invasion occurs only at the 
boundary between segments (rhombomeres). Outside of the brain, a growth factor called 
vascular endothelial growth factor (VEGF) is a potent stimulator of endothelial cell pro-
liferation, movement, and differentiation, but its role, if any, in brain angiogenesis is un-
known. My research delivered VEGF-A, or an antagonist (endostatin) of its receptor, into 
the hindbrain of quail embryos, using porous microbeads. The survivors, analyzed using 
immunocytochemistry, showed no change in the locations or numbers of endothelial 
cells penetrating the hindbrain, making this the first VEGF-independent vascularization 
site identified in vertebrate embryos.
This has been a great summer. Professor Drew Noden and the members of his lab 
not only taught me the necessary microsurgical and immunocytochemical skills for 
accomplishing my project but gave me the freedom to formulate my own concepts; 
they helped me to develop professionally in many ways. On that account I want to thank 
them enthusiastically.
Anna Moore | University of Bristol, Animal Behavior
A Retrospective Study of Inter-Dog Aggressive Behavior
I started my veterinary degree with the intention of becoming a surgeon and enter-
ing general practice. During my studies I developed an interest in animal behavior and 
suspended my veterinary studies for a year to gain an intercalated BSc in the subject. 
This gave me the opportunity to undertake research and sparked my interest in not only 
acquiring but also furthering knowledge in this field.
During my time at Cornell I had the privilege of working with Dr. Katherine Houpt in 
the Animal Behavior Clinic. My research took the form of a retrospective study of dogs 
presented at the clinic for aggression to other dogs in their household. The aim was to 
identify risk factors such as age or size differences between the animals, the composi-
tion of the household (i.e. number of males compared to females), as well as possible 
breed factors. With this knowledge it would be possible to offer pre-purchase advice to 
those hoping to add a dog to a household as well as possible identification of reasons for 
conflict, thus aiding treatment. In addition to the research I also had the opportunity to 
discuss incoming cases and current literature in the area and expanded my knowledge 
in the area of psychopharmacology—all of which added to my learning experience and 
increased my passion for this field.
I would like to thank Drs. David Fraser and Douglas McGregor for providing me with the 
honor of enjoying such a wonderful summer. I would also like to thank Drs. Houpt and 
Julia Albright for the advice and opportunities they have provided me and for their willing-
ness to answer all my questions.
29Dallas New | Ontario Veterinary College, Molecular Biology
Determining the Limit-Binding Domain of GAA1
I began my study of veterinary medicine one year ago fully knowing that I would prefer 
a career outside of typical clinical practice. However, becoming knowledgeable about 
available opportunities in such fields proved to be difficult. I applied to the Veterinary 
Leadership Program with the intention of discovering the different paths I could pursue 
after completing my degree.
This summer allowed me to gain invaluable research experience in an exceptional lab-
oratory facility. I was paired with Dr. Lisa Fortier, an incredible translational scientist 
and surgeon alike. It has been shown that chondrocytes lose their ability to respond 
to insulin-like growth factor-I (IGF-I) during aging and osteoarthritis, and this causes 
morphological changes in the cell through signaling molecules such as Cdc42, a small 
GTPase. Previous studies in Dr. Fortier’s laboratory have shown that Cdc42 interacts with 
a subunit of the transmembrane protein glycosylphosphatidylinositol-anchor transami-
dase complex, GAA1. The goal of my project was to test the hypothesis that Cdc42 
interacts with a mutated truncation of GAA1. It is the ultimate goal of this research to be 
able to specifically define how IGF-I affects GAA1 in chondrocytes during osteoarthritis in 
the hope that a novel pharmaceutical approach may be elucidated in the future.
I would like to thank everyone who made this summer such a success. In particular, 
thank you to Kira Novakofski and Laila Begum, who helped me with my research every 
step along the way. Thank you also to Dr. David Fraser and Dr. Douglas McGregor for 
making this program available and for dedicating so much energy into making it happen. 
This summer will not soon be forgotten!
Annelies Nijdam | Universiteit Utrecht, Physiology
Numerical Model of Blood-Flow Changes after Small-Scale Stroke
When I started vet school in 2001, I was already contemplating a career in research. Par-
ticipating in my faculty’s honors research program at Utrecht University in 2006 kindled 
my interest in multidisciplinary research and, as expected, the Leadership Program has 
proven to be the perfect next step in the development of my skills in the pursuit of a 
research career.
This summer I worked in Chris Schaffer’s lab on numerical modeling of rearrangements 
in cortical blood flow after small-scale strokes. Previous work within the lab using in 
vivo two-photon-laser-scanning microscopy in rodents resulted in large-scale maps of 
the network of arterioles on the brain surface, including topological connections, ves-
sel diameters, lengths, and flow velocity. Moreover, changes in blood flow in neighbor-
ing vessels in response to occlusion of an individual arteriole were quantified. These 
well-mapped networks have been numerically modeled as resistor networks. During the 
course of the summer I have expanded this model to conduct numerical experiments 
that model vessel occlusion and subsequent blood-flow rearrangements. My numerical 
results are consistent with the in vivo occlusion data and thus enable a more thorough 
study of flow rearrangements after microvascular occlusion, as well as the extrapolation 
of the effects of multiple occlusions on flow. These latter experiments are not feasible in 
vivo, so well-validated numerical simulations are critical.
I am very happy to have had the opportunity to work in a highly motivating environment 
with excellent scholars. My thanks go to all the people with whom I have worked for the 
inspiration and guidance they provided. I am especially grateful to Douglas McGregor and 
David Fraser for creating such an exceptional program.
30Ellen Petermeier | University of Minnesota, Bacteriology
The Evolutionary Genetics of Streptococcus uberis
As a child, I always imagined a career devoted to helping animals. After working in a 
veterinary hospital, I became concerned that a purely clinical career would never be one 
I truly desired. I needed discovery, challenge, and intrigue. I started my education at the 
University of Minnesota’s College of Veterinary Medicine, aware of the myriad of possibil-
ities that the profession could offer, but unable to obtain the experiences that could help 
narrow my options. In the Leadership Program, I was able to acquaint myself with various 
veterinary disciplines, which provided me with the insight and opportunity to develop my 
interests in a variety of veterinary fields.
This summer I investigated the evolutionary genetics of Streptococcus uberis. A clinically 
important bacterium, S. uberis is one of the major causative agents of bovine mastitis. 
S. uberis was previously thought to be an environmental pathogen, however, it appears 
now that it may be host adapted. Knowledge of the evolutionary genetics of S. uberis 
would allow us to better understand how to deal with this bacterium. The main objec-
tive of this study was to develop a phylogenetic tree of S. uberis. To accomplish this, 
I sequenced 14 housekeeping genes of 152 strains of S. uberis. The data were analyzed 
using eBURST and clonal frame analysis. The clonal groups were analyzed to find cor-
relations with host adaptability and geographic origin.
I would like to thank Douglas McGregor, David Fraser, and Melissa Restifo for providing 
this opportunity; my mentor, Michael Stanhope, and Paulina D. Pavinski Bitar for direct-
ing me in my research; and all others who helped make this program unforgettable.
Jessica Privett | University of Sydney, Virology
Development of a Novel Live-Attenuated Viral Vaccine  
for Bovine Herpesvirus Type 1
After four years of my veterinary degree studies that focused primarily on the roles of 
veterinarians in private practice, the Veterinary Leadership Program offered a chance 
to broaden my views on the opportunities and need for vets in other areas. During my 
veterinary studies in Sydney, I developed an interest in infectious disease, especially in 
relation to biosecurity and public health. The Leadership Program enabled me to inves-
tigate how I could pursue these interests as a career and to learn how vets can impact 
the profession in a significant way.
As part of my experience at Cornell, I worked in the Osterrieder lab developing a novel 
live-attenuated viral vaccine for bovine herpesvirus type 1 (BHV-1). BHV-1 is a significant 
cause of respiratory and reproductive disease in cattle and results in great economic 
losses to the bovine industry. Two gene coding regions, circ and gG, have been identified 
to be potentially involved in the immunosuppressive effects of BHV-1. My role was to 
create mutant viruses that could then be assessed as vaccine candidates. This involved 
mutation of the viral genome, screening for correct clones, transfection into mammalian 
cells, and extraction of live virus. This project allowed me to learn many new techniques 
in molecular biology, including PCR, restricted fragment length polymorphism, DNA prep-
aration, and tissue culture.
When I complete my veterinary degree, I plan to undertake a master of public health 
and/or master of business administration to prepare me for a career in a government or 
industry role.
I  sincerely  thank  the  Osterrieder  lab,  especially  Benedikt  Kaufer,  and  all  my  fellow 
Leadership Program participants for a great summer.
31Kimberley Schiller | University of Edinburgh, Renal Physiology
Localization and Heterologous Expression of a 
Mosquito Ion-Exchanger
Since beginning my veterinary studies I have wanted to pursue a career that would incor-
porate research. I discovered that I enjoy research prior to beginning my studies—during 
my internship in the United Nations laboratory outside of Vienna. Research is both intel-
lectually challenging and exciting. This is why the Leadership Program has been one of 
the most rewarding and enriching experiences I have had; it has opened broad horizons 
of different career paths for me to pursue.
This summer I worked in Klaus Beyenbach’s laboratory, where I studied Malpighian tu-
bules of the yellow fever mosquito (Aedes aegypti). Insect Malpighian tubules are in-
valuable physiological models for determining mechanisms and regulation of epithelial 
transport. Both provide important insight into renal and epithelial physiology and also to 
diseases affecting animal and human health.
My research project involved localizing the expression of a putative anion exchanger 
(AE) in Malpighian tubules and determining if the AE protein can be expressed by frog 
(Xenopus laevis) oocytes, a common expression system used to characterize the function 
of AE-like proteins. First, I used in situ hybridization on mosquito Malpighian tubules and 
gut tissue to localize where expression of the AE mRNA occurs. Second, I injected mRNA 
encoding the AE protein (with a fluorescent tag) into frog oocytes to determine the opti-
mal amount of mRNA and timeframe for heterologous expression of the mosquito AE.
I would like to thank Dr. Peter Piermarini for his invaluable guidance. Also, I am grateful 
to Professor Beyenbach for giving me the opportunity to work with his team. The Leader-
ship Program has been a particularly exciting experience.
James Swann | Cambridge University, Microbiology
Manipulation of Secretary Pathways in Tetrahymena thermophila
During my studies at the University of Cambridge, I developed a keen interest in the 
future of the veterinary profession and in career options that might be open to me upon 
graduation. I applied to the Leadership Program in the hope of gaining a greater under-
standing of these subjects. In addition to achieving my goal, I have learned a great deal 
more than I expected about the qualities of leadership, the myriad challenges facing 
current veterinarians, and the scientific process in general. I am currently considering 
studying for a higher degree when I complete my veterinary training in 2010.
My laboratory project concerned the ciliate Tetrahymena thermophila, a unicellular eu-
karyote that represents a highly efficient system for the production of vaccine proteins 
encoded by genes from other species. One candidate for production within this system 
is the protein Pfs48/45 produced by Plasmodium falciparum, the causative agent of 
cerebral malaria. As Pfs48/45 is only displayed on the surface of parasite stages in the 
mosquito vector (Anopheles sp.), it has potential for use as a component of transmission-
blocking vaccines. If the mammalian host is immunized against such a molecule, this can 
then be recognized and targeted within the vector. I tested the hypothesis that different 
yields of protein might be obtained by targeting Pfs48/45 to different protein-sorting 
pathways. I used a variety of molecular and genetic techniques to produce several dif-
ferent versions of the gene encoding Pfs48/45, each containing targeting sequences. 
I also investigated whether antigenic vaccine preparations could be prepared directly 
from similarly transformed cells.
I am extremely grateful to all those who have made this summer so enjoyable.
32 32Heidi Vesterinen | Helsinki University, Epidemiology
Dynamics of Antibiotic Resistance in Livestock
When I started vet school I wanted to know how organisms function and develop. It soon 
became evident that too much is still unknown, and so I decided to pursue a career in 
research. Applying to the Leadership Program was the first major step toward realizing 
that goal.
The topic of my research project was the emergence of antimicrobial resistance in live-
stock. Very little mathematical modeling has been done on this. I developed a mathemat-
ical model to address the question: “What happens inside an animal when an infection 
is treated with an antimicrobial agent?” The model has three components. It estimates 
the antibiotic concentrations in different body compartments, the effect of antibiotic on 
bacteria, and the growth of bacteria. I used as the case study, marbofloxacin treatment of 
calves with E. coli infections. The results suggest that for this drug, a single high dose is 
the best way to minimize the emergence of resistance. A sensitivity analysis of my model 
indicated that the emergence of mutations was influenced by the pharmacodynamic 
parameters of the susceptible strain, the absorption rate of the drug, and the mutation 
rate of the bacteria.
The Leadership Program has been an invaluable experience. I would like to thank the 
whole modeling group for showing me how to plan a study and how to think like a re-
searcher. I am especially grateful to Yrjö Gröhn for inviting me into his research group 
and to Cristina Lanzas for being such a superb modeling teacher. I would also like to 
thank David Fraser, Douglas McGregor, and all the other facilitators for their valuable 
thoughts and great career tips.
Melissa Restifo
Program Coordinator
I could never have predicted how much I would 
enjoy the experience of serving as coordinator 
of the Leadership Program. Observing the aca-
demic  and  social  interactions  of  such  bright, 
ambitious  individuals  was  enjoyable  and  re-
warding and opened my eyes to the plethora of 
opportunities afforded to those in the veterinary 
profession. The personal and professional dis-
coveries that were made over the course of only 
10  weeks  truly  demonstrates  the  magnificent 
things that can happen when great minds come 
together. Perhaps the greatest honor, however, 
was witnessing the forging of what I am sure will 
be long-lasting relationships between members 
of a diverse group, myself included. I wish each 
student the best of luck in future endeavors, and 
I have no doubt that their leadership skills and 
drive to succeed will help take them to great 
heights in years to come.
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Kirk Adams
Facilitator
Director, Strategic Planning
Pfizer Animal Health
Philip Carter
Facilitator
Professor Emeritus,  
Microbiology, 
North Carolina State University
Richard Cerione
Counselor
Professor, Pharmacology and 
Chemical Biology, 
Cornell University
Ruth Collins
Counselor
Associate Professor, 
Molecular Medicine, 
Cornell University
William Horne
Facilitator
Professor, 
Anesthesiology
Cornell University
Charlie Hsu
Facilitator
Research Veterinarian, 
Laboratory Animal Resources
Merck Co.
Margaret McCann
Facilitator
Associate Director, 
Worldwide Regulatory Affairs, 
Merck Co.
Sean McDonough
Counselor
Associate Professor, 
Pathology
Cornell University
Lisa Fortier
Facilitator
Professor, 
Clinical Sciences
Cornell University
David Fraser
Facilitator/Counselor
Professor Emeritus, 
Animal Science, 
University of Sydney
Michelle Haven
Facilitator
Vice President, Business 
Development, Licensing 
and Strategic Planning
Pfizer Animal Health
Gerard Hickey
Facilitator
Director, 
Worldwide Regulatory Affairs, 
Merck Co.
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for the 2008 Leadership Program
Douglas McGregor
Counselor
Director,
Leadership and
Training Initiatives
Cornell University
Suzanne McGregor
Facilitator
Eastern Regional Counsel, 
Immigration, Department of 
Homeland Security
Frederick Murphy
Facilitator
Professor, Pathology
University of Texas
Medical Center
Malden Nesheim
Facilitator
Professor Emeritus, 
Nutritional Sciences, 
Cornell University
John Parker
Facilitator
Assistant Professor, Virology
Baker Institute for 
Animal Health, 
Cornell University
Colin Parrish
Facilitator
Professor, Virology
Baker Institute for 
Animal Health, 
Cornell University
Roy Pollock
Facilitator
President,
Fort Hill Company
Andrew Sage II
Facilitator
President,
Sage Capital Corp.
Alfonso Torres
Facilitator
Associate Dean, 
Veterinary Public Policy
Cornell University
Maurice (“Pete”) White
Facilitator
Professor, 
Population Medicine
Cornell University
35Participants in the 2008 Leadership Program were 
housed  in  the  Zeta  Psi  fraternity  house  on  the 
Cornell	 campus.	 They	 had	 exclusive	 use	 of	 the	
building for the 10-week period that the program 
was  in  session.  Several  events  were  scheduled 
there, typically in the evening in conjunction with a 
catered meal. The living arrangements enabled the 
scholars to socialize and relax in a convenient and 
pleasant campus environment.
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Time Out
Apart  from  their  intensive  schedule, 
program scholars found time for many 
personal pleasures. They capitalized on 
local Ithaca amenities and also visited 
Boston,	Niagara	Falls,	New	York	City,	
and	Washington,	DC.Activities 2006
38
Program Dinner
The Leadership Program scholars hosted a dinner 
for their mentors, module facilitators, counselors, 
and  other  guests  at  Willard  Straight  Hall  on  the 
Cornell	University	campus.Where Are They 
Now? The  program  organizers  maintain  contact  with  Leadership  Program 
graduates	in	order	to	strengthen	the	professional	network	forged	at	Cornell	
and to uphold the program’s tradition of excellence for the benefit of future 
fellows.  Listed  below  are  the  positions  currently  occupied  by  program 
graduates who have completed their veterinary education and are pursuing 
careers in science or public health.
1990
John Angelos		Assistant	Professor,	Food	Animal	Medicine,	University	of	California,	Davis
William Carr		Instructor,	Massachusetts	General	Hospital/Partners	AIDS	Research	Center,	Harvard	University,	Boston,	
Massachusetts
Laura Gumprecht  Associate Director, Safety Assessment, Merck Research Laboratory, West Point, Pennsylvania
Elizabeth Lyon Hannah  Research Faculty, Boise State University, Boise, Idaho
Richard Haworth  Senior Pathologist, GlaxoSmithKline, Middlesex, United Kingdom
Melissa Mazan  Associate Professor and Director, Sports Medicine, Tufts University, North Grafton, Massachusetts
Rebecca Papendick		Associate	Pathologist,	Zoological	Society	of	San	Diego,	California
Susan Schaefer 	Clinical	Assistant	Professor,	Surgery,	University	of	Wisconsin,	Madison
A. W. (Dan) Tucker 	Senior	Lecturer,	Veterinary	Public	Health,	University	of	Cambridge,	United	Kingdom
Thomas Vahlenkamp  Assistant to the President, Friedrich-Loeffler-Institut, Greifswald, Germany
1991
Prema Arasu		Associate	Vice	Provost,	International	Academics,	North	Carolina	State	University,	Raleigh,	North	Carolina
David Bainbridge 	Clinical	Veterinary	Anatomist,	University	of	Cambridge,	United	Kingdom
Linda Berent		Clinical	Assistant	Professor,	University	of	Missouri,	Columbia,	Missouri
Ian Davis 	Associate	Professor		Genomics	and	Pathobiology,	Ohio	State	University,	Columbus,	Ohio
Dianne Hellwig		Associate	Professor,	Agriculture	and	Natural	Resources,	Berea	College,	Kentucky
Judy Hickman-Davis  Assistant Professor, Department of Veterinary Preventive Medicine, Ohio State University, 
Columbus,	Ohio
Alan Radford  Senior Lecturer, Small-Animal Studies, University of Liverpool, United Kingdom
Jean Reichle		Head,	Animal	Surgical	and	Emergency	Center,	West	Los	Angeles,	California
391992
Tomasz Betkowski 	Medical	Representative,	Eli	Lilly	Co.,	Poland
Stephen Davies  Assistant Professor, Parasitology, Uniformed Services University, Bethesda, Maryland
Mathew Gerard 	Assistant	Professor,	Surgery,	North	Carolina	State	University,	Raleigh,	North	Carolina
Christine Hawke		Lecturer,	Small-Animal	Clinical	Practice,	University	of	Sydney,	Australia
Jacqueline Phillips  Senior Lecturer, Physiology, Murdoch University, Perth, Australia
Cristina Rodriguez-Sanchez  Senior Research Associate, Universidad Nacional Autónoma de México, 
Mexico	City,	Mexico
Louise Southwood		Assistant	Professor,	Emergency	and	Critical	Care,	University	of	Pennsylvania, 
Philadelphia, Pennsylvania
Reinhard Straubinger  Professor and Head, Department of Bacteriology and Mycology, Ludwig-Maximilians-Uni-
verstät München, Munich, Germany
1993
Virginia Fajt		Clinical	Assistant	Professor,	Texas	A&M	University,	College	Station,	Texas
Christopher Laing		Director,	Science	and	Technology,	University	City	Science	Center,	Philadelphia,	Pennsylvania
Emma O’Neill		Lecturer,	Small-Animal	Medicine,	University	College,	Dublin,	Ireland
Joanne Rainger  Registrar, Anesthesia, University of Sydney, Australia
Ashley Reynolds  Associate Research Scholar, Virology, Princeton University, Princeton, New Jersey
Susanna Ryan		Communications	Specialist,	MediTech	Media,	London,	United	Kingdom
Veiko Saluste  Executive, Interchemi, Talin, Estonia
Melinda Stewart  Pathologist, EMAI Diagnostic Services, Menangle, Australia 
Lynn Wachtman		Clinical	Veterinarian,	New	England	Primate	Center,	Southborough,	Massachusetts
1994
Melissa Beall  Research Scientist, IDEXX Inc., Westbrook, Minnesota
Larissa Bowman		Director,	Mountain	Veterinary	Pathology,	Ashville,	North	Carolina
Leslie Gabor  Laboratory Leader, EMAI Diagnostic Services, Menangle, Australia
Maria Lara-Tejero		Research	Associate,	Department	of	Microbiology,	Yale	University,	New	Haven,	Connecticut
Christopher Mariani  Associate Professor, Neurology, University of Florida, Gainesville, Florida
Sonia Mumford 	Veterinary	Medical	Officer,	Fish	Health	Center,	Olympia,	Washington
Jeffrey Phillips  Assistant Professor, Oncology, University of Tennessee, Knoxville, Tennessee
Julie Pomerantz  Associate Research Scientist, Wildlife Trust, Palisades, New York
Stacy Pritt 	Director	Regulatory	Operations,	Covance	Research	Products,	Inc.,	Denver,	Pennsylvania
Mary Thompson		Academic	Clinician,	University	of	Queensland,	Australia
Oliver Turner  Pathologist, Novartis Inc., East Hanover, New Jersey
401995
Elizabeth Adkins		Clinical	Instructor,	Comparative	Ophthalmology,	University	of	Wisconsin,	Madison,	Wisconsin
Gertraut Altreuther  Project Manager, Parasitology, Bayer Animal Health, Leverkusen, Germany
Philippa Beard  Lecturer, Virology, University of Edinburgh, Scotland, United Kingdom
Kate Creevy  Assistant Professor, Infectious Diseases, University of Georgia, Athens, GA
Rachael Gray  Lecturer, Veterinary Anatomy, University of Sydney, Australia
Wendy Harrison		Research	Scientist,	GlaxoSmithKline,	Medicines	Research	Center,	Stevenage,	United	Kingdom
Kelly Lorschy  Technical Service Specialist, Pfizer, Australia
Andrew Moorhead  Diagnostic Laboratory Scientist, University of Georgia, Athens, Georgia
Tony Mutsaers		Adjunct	Assistant	Professor,	Ontario	Veterinary	College,	Guelph,	Ontario
1996
Michelle Dries-Kellaway  Research Project Manager, University of Wollongong, New South Wales, Australia
Margaret Fleischli  Research Specialist, School of Medicine and Public Health, University of Wisconsin, 
Madison, Wisconsin
Patricia Gearhart  Adjunct Assistant Professor, Ophthalmology, Michigan State University, East Lansing, Michigan
Tamara Gull  Assistant Professor, Pathobiology, Oklahoma State University, Stillwater, Oklahoma
Antonia Jameson-Jordan		Instructor,	Biomedical	Sciences,	Cornell	University,	Ithaca,	New	York
Allison Stewart  Associate Professor, Large Animal Medicine, Auburn University, Montgomery, Alabama
Edwin van Duijnhoven  Research Scientist, NOTOX, Hertogenbosch, Netherlands
Constantin Von der Heyden  Practice Director, Pegasys Strategy and Development, Pretoria, 
Republic of South Africa
1997
Dennis Bailey		Lecturer,	Oncology,	Cornell	University,	Ithaca,	New	York
Peter Bracken		Technical	Service	Manager,	Fort	Dodge	Co.,	Australia
Jonathan Happold  Senior Veterinary Officer, Biosecurity, Australia
Esther Kornalijnslijper  Lecturer, Infectious Diseases, Universiteit Utrecht, Netherlands
Tanya LeRoith		Assistant	Professor,	Pathology,	Virginia-Maryland	College	of	Veterinary	Medicine,	Blacksburg,	Virginia
Lucy Neave		Lecturer,	Creative	Writing,	Australian	National	University,	Canberra,	Australia
Patricia Pesavento		Associate	Professor,	Pathology,	University	of	California,	Davis,	California
Paul Plummer  Assistant Professor, Microbiology, Iowa State University, Ames, Iowa
Deborah Prattley  Lecturer, Veterinary Public Health, Massey University, New Zealand
Jonathan Werner		Principal	Pathobiologist,	Amgen	Co.,	Thousand	Oaks,	California
Esther Wissink  Research Manager, Virology, Universiteit Utrecht, Netherlands
411998
Max Bastian  Senior Postdoctoral Fellow, Institut für Klinische Mikrobiologie, Immunologie und Hygiene, University of 
Ulm, Germany
Erin Crotty [Phipps] 	Health	Promotion	Specialist,	New	Mexico	Department	of	Health,	Albuquerque,	New	Mexico
Stephen Fleischer		Team	Leader,	Center	for	Veterinary	Medicine,	Federal	Drug	Administration,	Frederick,	Maryland
Karsten Hüffer  Assistant Professor, Virology, University of Alaska, Fairbanks, Alaska
Mary Klinck  Resident, Behavioral Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Zoe Lenard  Senior Lecturer, Diagnostic Imaging, Murdoch University, Perth, Australia
Karen Liljebjelke  Research Microbiologist, U.S. Department of Agriculture, Athens, GA
Larissa Minicucci  Director, DVM/MPH Program, University of Minnesota, Minneapolis, Minnesota
Amanda Murphie [de Mestre] 	Lecturer,	Veterinary	Basic	Sciences,	Royal	Veterinary	College,	London,	United	Kingdom
Anne-Marije Sparnaaij  Senior Policy Officer, Ministry of Agriculture, Netherlands
1999
Elmer Ahrens  Resident Animal Medicine, Kleintierklinik, Rhenus, Switzerland
Erica Behling-Kelly		Resident,	Clinical	Pathology,	University	of	Wisconsin,	Madison,	Wisconsin
Christine Broster 	Veterinary	Clinical	Research	Scientist,	University	of	Bristol,	United	Kingdom
Robert Dickens		Training	Specialist,	U.S.	Department	of	Agriculture,	Raleigh,	North	Carolina
Peter Florian  Laboratory Head, Thrombosis, Sanofi-Aventis, Frankfurt, Germany
Francette Geraghty [Dusan]  World Health Organization Epidemiologist, Vientiane, Lao People’s Democratic Republic
Carl Holmgren  Staff Scientist, Neural Sciences, Karolinska Institutet, Stockholm, Sweden
Emily Meseck		Principal	Pathologist,	Wyeth	Research	Laboratories,	Collegeville,	Pennsylvania
Rachel Mo-Peters		Instructor,	Pathology,	Cornell	University,	Ithaca,	New	York
Mary Nabity 	Clinical	Assistant	Professor,	Texas	A&M	University,	College	Station,	Texas
Kimberly Newkirk  Assistant Professor, Anatomical Pathology, University of Tennessee, Knoxville, Tennessee
Christopher Premanandan		Assistant	Professor,	Veterinary	Biosciences,	Ohio	State	University,	Columbus,	Ohio
Rachel Tarlinton  Lecturer, Preclinical Veterinary Medicine, University of Nottingham, United Kingdom
Holger Volk		Lecturer,	Neurology,	Royal	Veterinary	College,	United	Kingdom
2000
Beatrice Bohme  Resident, Small-Animal Surgery, Faculty of Veterinary Medicine, University of Liege, Liege, Belgium
Steven Daley		Postdoctoral	Fellow,	Immunology,	Australian	National	University,	Canberra,	Australia
Katharine Evans		Deputy	Veterinary	Surgeon,	Babraham	Institute,	University	of	Cambridge,	United	Kingdom
Toby Floyd		MPH	Candidate,	Royal	Veterinary	College,	London,	United	Kingdom
Rachel Geisel  (Allavena) Pathologist, Pfizer Inc., Sandwich, United Kingdom
Samuel Hamilton  Veterinary Officer, Department of Agriculture, Fisheries, and Forestry, Australia
Birgit Hingerl [Viertlboeck]  Scientific Assistant, Immunology, University of Munich, Germany
Natali Krekeler  PhD candidate, Theriogenology, University of Melbourne, Australia
Jamie Lovaglio 	Resident,	Laboratory	Animal	Medicine,	University	of	Illinois,	Chicago,	Illinois
Richard Luce		Resident	Advisor,	U.S.	Centers	for	Disease	Control	and	Prevention,	Field	Epidemiology	and 
Laboratory Training Program, Addis Ababa, Ethiopia
Silke Meerman		DrMedVet	Candidate,	Leibniz	Universität,	Hannover,	Germany
Fiona Norris Sansom  Postdoctoral Fellow, Microbiology, University of Melbourne, Australia
Knut Stieger  Research Assistant, Laboratory of Ophthalmology, University of Giessen, Germany
Joost Uilenreef  Faculty Service Specialist, Anesthesiology, Universiteit Utrecht, Netherlands
Kevin Woolard 	PhD	candidate,	National	Cancer	Institute,	NIH,	Bethesda,	Maryland
422001
Julie Chevrette		Clinical	Veterinarian,	Charles	River	Laboratory,	Montreal,	Quebec,	Canada
Meagan Green		Intern,	Equine	Medicine,	Rood	and	Riddle	Hospital,	Lexington,	Kentucky
Katherine Hughes		Resident,	Pathology,	University	of	Cambridge,	United	Kingdom
Karin Holzer		PhD	candidate,	Virology,	Cornell	University,	Ithaca,	New	York
Stephanie Janeczko 	Resident,	Shelter-Animal	Medicine,	Cornell	University,	Ithaca,	New	York
Charles Johnson  PhD candidate, Pathology, Iowa State University, Ames, Iowa
Robert Klopfleisch  Postdoctoral Fellow, Freie Universität, Berlin, Germany
Rebecca Lin  Resident, Small-Animal Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
David Loch		Postdoctoral	Fellow,	Comparative	Medicine,	Johns	Hopkins	University,	Baltimore,	Maryland
Maeva May		Resident,	Large-Animal	Medicine,	University	of	Pennsylvania,	New	Bolton	Center,	Pennsylvania
Timothy Myshrall 	Assistant	Director,	Veterinary	Services,	Cleveland	Clinic,	Cleveland,	Ohio
Kis Robertson 	EIS	Trainee,	U.S.	Centers	for	Disease	Control	and	Prevention,	Atlanta,	Georgia
Simon Starkey		Resident,	Avian	and	Exotic	Medicine,	Cornell	University,	Ithaca,	New	York
Jason Stayt		Resident,	Clinical	Pathology,	Murdoch	University,	Perth,	Australia
Amy Warren-Yates		Assistant	Professor,	Pathology,	University	of	Calgary,	Canada
Rachel Winsor (Ballantyne)  Technical Manager, Merial Animal Health Ltd., Harlow, United Kingdom
Robin Yates		Assistant	Professor,	Comparative	Biology,	University	of	Calgary,	Canada
Bevin Zimmerman		PhD	candidate,	Pathobiology,	Ohio	State	University,	Columbus,	Ohio
2002
Janet Beagley  Intern, Large-Animal Medicine, University of Georgia, Athens, Georgia
Karin Darpel  PhD candidate, Parasitology, Pirbright Laboratory, Institute for Animal Health, Surrey, United Kingdom
Karyn Havas		PhD	candidate,	Epidemiology,	Colorado	State	University,	Fort	Collins,	Colorado
Patrick Kenny		Lecturer,	Neurology,	Royal	Veterinary	College,	London,	United	Kingdom
Steven Laing		PhD	Candidate,	Pharmacology,	University	of	Glasgow,	Scotland,	United	Kingdom
Susannah Lillis  Resident, Diagnostic Imaging, University of Pennsylvania, Philadelphia, Pennsylvania
Anne Lo		PhD	candidate,	Virology,	University	of	Cambridge,	United	Kingdom
Michael Mienaltowski		PhD	candidate,	Cell	Biology,	University	of	Kentucky,	Lexington,	Kentucky
Andrew Miller		Diagnostic	Pathologist,	New	England	Primate	Center,	Southborough,	Massachusetts
Simon Priestnall		Resident,	Pathology,	Royal	Veterinary	College,	London,	United	Kingdom
Kelly Still  U.S. Army Veterinarian, Enterprise, Alabama
Barbara Taennler  Marketing Manager, Veterinaria, Zurich, Switzerland
Ryan Taggert  Intern, Small-Animal Medicine and Surgery, Mississippi State University, Starkville, Mississippi
Anke Werner  PhD candidate, Medical School, University of Hannover, Germany
432003
Rosie Allister  PhD candidate, Public Health Services, University of Edinburgh, Scotland, United Kingdom
Mieke Baan 	Resident,	Small-Animal	Medicine,	Ohio	State	University,	Columbus,	Ohio
John Baker  DPhil candidate, University of Oxford, United Kingdom
Sandra Barnard 	Resident,	Oncology,	Cornell	University,	Ithaca,	New	York
Belinda Black  Intern, Small-Animal Medicine, Murdoch University, Perth, Australia
Patrick Carney 	Resident,	Small-Animal	Medicine,	Oregon	State	University,	Corvallis,	Oregon
Amy Cordner  Resident, Small-Animal Medicine and Surgery, University of Minneapolis, Minnesota
David Gardner 	Resident,	Pathology,	Colorado	State	University,	Fort	Collins,	Colorado
Erica Gruber 	Intern,	Small-Animal	Medicine	and	Surgery,	Colorado	State	University,	Fort	Collins,	Colorado
Carol Haak 	Resident,	Critical	Care,	University	of	Missouri,	Columbia,	Missouri
Lindsay Hamilton 	PhD	candidate,	Neurophysiology,	University	of	Cambridge,	United	Kingdom
Jutta Klewitz  DrMedVet candidate, Leibniz Universität, Hannover, Germany
Michael Krahn 	Postdoctoral	Fellow,	Stem-Cell	Biology,	Georg-August-Universität,	Göttingen,	Germany
Heather Martin  Resident, Laboratory-Animal Medicine, Massachusetts Institute of Technology, Boston, Massachusetts
Siobhan Mor  PhD candidate, Parasitology, Tufts University, North Grafton, Massachusetts
Kate Paterson  PhD candidate, Garvan Institute of Medical Research, University of New South Wales, Sydney, Australia
Myank Seth  Resident, Small-Animal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Karla Stucker 	PhD	candidate,	Cornell	University,	Ithaca,	New	York
Lyn Wancket 	Resident,	Pathology,	The	Ohio	State	University,	Columbus,	Ohio	
Christiane Wrann  PhD candidate, Medical School, University of Hannover, Germany
2004
Anton Asare  Public Health Veterinarian, U.S. Department of Agriculture, Amarillo, Texas
Carolin Block  Medical Management Trainee, Roche Pharma AG, Grenzach-Wyhlen, Germany
Mathew Breed 	Resident,	Ambulatory	Medicine,	Cornell	University,	Ithaca,	New	York
Andrew Broadbent 	PhD	candidate,	Dermatology,	Imperial	College,	London,	United	Kingdom
Angelique Della Volpe  DrMedVet candidate, University of Leipzeig, Germany
Karla Dreckmann  Postdoctoral Fellow, Immunology, Medical School, Hannover, Germany
Annika Krengel  DrMedVet candidate, Institute for Zoo and Wildlife Research, Berlin, Germany
Duncan Russell 	Resident,	Pathology,	Cornell	University,	Ithaca,	New	York
Baukje Schotanus 	PhD	candidate,	Cell	Biology,	Universiteit	Utrecht,	Netherlands
Katherine Scollan 	Resident,	Cardiology,	Oregon	State	University,	Corvallis,	Oregon
Ivana Sekis  DrMedVet candidate, Oncology, University of Vienna, Austria
Katy Townsend 	MS	candidate,	Ohio	State	University,	Columbus,	Ohio
Claire Underwood 	Fellow	in	Cardiology,	University	of	Pennsylvania,	New	Bolton	Center,	Kennett	Square,	Pennsylvania
442005
Melanie Ammersbach 	PhD	candidate,	Clinical	Pathology,	Ontario	Veterinary	College,	Guelph,	Ontario,	Canada
Hannah Bender 	PhD	candidate,	Oncology,	Australian	National	University,	Canberra,	Australia
Hille Fieten  PhD candidate, Genetics, University of Utrecht, Netherlands
Kanika McAlpine (Singleton)  U.S. Army Veterinarian, Monmouth, New Jersey
Marieke Opsteegh  PhD candidate, Parasitology, Dutch National Institute for Public Health, Netherlands
Patricia Oura 	Intern,	Small-Animal	Medicine,	North	Carolina	State	University,	Raleigh,	North	Carolina
Bo Raphael  Invasive Species Scientist, Bureau of Rural Sciences, Australia
Johanna Rigas 	Resident,	Clinical	Pathology,	Oregon	State	University,	Corvallis,	Oregon
Ruth Schmitte  DrVetMed candidate, Neuroanatomy, Medical School, University of Hannover, Germany
Kai-Biu Shiu  Resident, Oncology, University of Wisconsin, Madison, Wisconsin
Timothy Stell 	Intern,	Small-Animal	Medicine	and	Surgery,	Darien	Animal	Hospital,	Darien,	Connecticut
Catherine Trickett  PhD candidate, Animal Behavior, Bristol University, Bristol, United Kingdom
Nina Weishaupt 	PhD	candidate,	Neuroscience,	University	of	Calgary,	Canada
Collin Wolff 	Intern,	Surgery,	Dallas	Veterinary	Surgical	Center,	Dallas,	Texas
2006
Janny de Grauw  PhD candidate, Pathology, Universiteit Utrecht, Netherlands
Amanda DeMaster 	Intern,	Small-Animal	Clinical	Sciences,	Texas	A&M	University,	College	Station,	Texas
Louise FitzGerald  Resident, Pathology, Murdoch University, Perth, Australia
Annika Haagsman  Intern, Surgery, Universiteit Utrecht, Netherlands
Eva-Maria Laabs  PhD candidate, Parasitology, Leibnitz Universität, Hannover, Germany
Jane Leadbeater 	Intern,	Equine	Surgery,	Scone	Veterinary	Hospital,	Scone,	New	South	Wales,	Australia
Gelja Maiwald  PhD candidate, Biotechnology, University of Hannover, Germany
Richard Meeson 	Resident,	Small-Animal	Surgery,	Royal	Veterinary	College,	London,	United	Kingdom
Joseph Neary 	Intern,	Livestock	Medicine	and	Surgery,	Colorado	State	University,	Fort	Collins,	Colorado
John Parker 	Resident,	Neurology,	Cambridge	University,	United	Kingdom
Timothy Reed  Resident, Pathology, Purdue University, West Lafayette, Indiana 
Swaantje Roth  PhD candidate, Vaccinology, Freie Universität, Berlin, Germany
2007
Rosemary Brungs  Medical Student, University of Sydney, Australia
Elva Cha 	PhD	candidate,	Epidemiology,	Cornell	University,	Ithaca,	New	York
Ludwig Groebler  PhD candidate, Biomedicine, University of Sydney, Australia
Laura Grogan  Intern, Animal Referral Hospital, Strathfield, New South Wales, Australia
Shen Yang 	PhD	candidate,	Molecular	and	Cellular	Biology,	University	of	Maryland,	College	Park,	Maryland
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Say?
“If you are about to enter the Leadership Program, 
don’t go with any other expectation than to enjoy 
it. But be prepared for it to change your life.”
—Alan Radford, 1991
“My time at Cornell is one I will always cherish and 
has been a key factor in many of my career decisions.”
—Oliver Turner, 1994
“Vet grad programs all over the world are becoming 
filled with Leadership Program alums.”
—Tony Mutsaers, 1995
“What a fantastic experience it was.”
—Sophia Tzannes, 1997
“I have such happy memories of 
the Leadership Program.”
—Christine Broster, 1999
“I still think of the wonderful time I had  
at Cornell and the great friends I met.”
—Susannah Lillis, 2002
47“I still love to look back to that 
great summer and the valuable 
experiences I gained.”
—Eva-Maria Laabs, 2006
“I remember that wonderful sum-
mer in the Leadership Program.”
—Mieke Baan, 2003
“The Leadership Program propelled me  
along the career path I am now pursuing.”
—Steven Daley, 2000
“I am passionate about the  
Leadership Program as it gave me  
a valuable insight into research.”
—Kate Hughes, 2001
“I miss Ithaca, Cornell, and especially 
the Leadership Program.”
—Maria Volkmann, 2007
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In the 
Limelight
Richard 
Luce
Upon entering veterinary 
school at North Carolina 
State University, I intended 
to pursue a career in large-
animal  clinical  practice. 
During  my  first  year, 
at the suggestion of my 
microbiology professor Dr. 
Philip Carter, I applied to the 
Cornell Leadership Program. 
Little did I suspect that this 
seemingly minor decision 
about how to spend my 
upcoming summer would 
have  such  a  profound 
impact on my career choice. 
During  my  10  weeks  in 
Ithaca I worked with Drs. 
Judith Appleton and Dorothy 
Ainsworth,  studying  the 
effect of exercise on cellular 
immune function in horses. 
My research, combined with other program activities, demonstrated the multitude of ways that veterinarians could use their 
training. Most importantly, I developed the desire and confidence to explore the “path least traveled” and seek opportunities 
where I could creatively use my veterinary education.
An increasing number of public health problems confronting humans are closely associated with infectious diseases of animals. 
While most clearly demonstrated with avian influenza, other diseases—including Rift Valley Fever, brucellosis, and rabies—continue 
to present public health challenges in various parts of the world. These developments have created unprecedented demand for 
veterinarians in non-traditional careers such as public health practice. The Leadership Program is a vital link between veterinary 
students and these burgeoning opportunities.
After completing my veterinary degree, I began an internship in large-animal medicine and surgery at Texas A&M University, 
where I developed a desire to explore the epidemiology of the diseases and conditions I encountered in clinical work. Thanks 
to a scholarship from Rotary International, I enrolled in an MPhil program jointly coordinated by the University of Cambridge 
School of Veterinary Medicine and the Animal Health Trust. My research focused on the epidemiology of cellular immune 
response to equine herpesvirus-1 in a population of Thoroughbred horses. Seeking further training in epidemiology, I accepted 
a position with the U.S. Centers for Disease Control and Prevention’s Epidemic Intelligence Service. Assigned to the Wyoming 
Department of Health, I assisted the state to develop epidemiologic capacity to address public health issues while I gained 
expertise in the field of public health. During this time, I had the opportunity to serve as a member of the CDC public health 
response teams, deployed to address the aftermath of Hurricane Katrina in Louisiana. Later, I assisted the Nigerian Ministry of 
Health to implement prevention and control measures on the discovery of avian influenza in the nation’s poultry flocks. After 
two years, I was accepted by the CDC’s preventive medicine fellowship program and served as an epidemiologist working on 
dengue fever in San Juan, Puerto Rico.
Shortly, I will begin a new position with the CDC in Ethiopia. As a resident advisor to the Ministry of Health, I will be instituting 
a field epidemiology and laboratory training program aimed at assisting the nation to develop self-sustaining epidemiologic 
expertise and public health infrastructure. Although I often encounter surprise that a veterinarian would be working outside the 
confines of veterinary practice, there is no doubt that veterinary training is becoming increasingly valuable in addressing pressing 
global public health issues. Appropriately trained veterinarians can have a critically important role in the search for solutions to 
these problems.For more information about the Leadership Program, contact:
Douglas D. McGregor, Director
Leadership Program for Veterinary Students
James A. Baker Institute for Animal Health
College of Veterinary Medicine
Cornell University
Ithaca, NY 14853
phone: 607 256-5638
fax: 607 256-5608
email: ddm7@cornell.edu
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